Suppr超能文献

一种从前列腺癌组织消化物中纯化特定范围内天然蛋白质的有效方法。

An efficient method for native protein purification in the selected range from prostate cancer tissue digests.

作者信息

Ahmad Rumana, Nicora Carrie D, Shukla Anil K, Smith Richard D, Qian Wei-Jun, Liu Alvin Y

机构信息

Department of Urology, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA.

Biological Science Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

出版信息

Chin Clin Oncol. 2016 Dec;5(6):78. doi: 10.21037/cco.2016.12.03.

Abstract

BACKGROUND

Prostate cancer (CP) cells differ from their normal counterpart in gene expression. Genes encoding secreted or extracellular proteins with increased expression in CP may serve as potential biomarkers. For their detection and quantification, assays based on monoclonal antibodies are best suited for development in the clinical setting. One approach to obtain antibodies is to use recombinant proteins as immunogen. However, the synthesis of recombinant protein for each identified candidate is time-consuming and expensive. It is also not practical to generate high quality antibodies to all identified candidates individually. Furthermore, non-native forms (e.g., recombinant) of proteins may not always lead to useful antibodies. Our approach was to purify a subset of proteins from CP tissue specimens for use as immunogen.

METHODS

In the present investigation, ten cancer specimens obtained from cases scored Gleason 3+3, 3+4 and 4+3 were digested by collagenase to single cells in serum-free tissue culture media. Cells were pelleted after collagenase digestion, and the cell-free supernatant from each specimen were pooled and used for isolation of proteins in the 10-30 kDa molecular weight range using a combination of sonication, dialysis and Amicon ultrafiltration. Western blotting and mass spectrometry (MS) proteomics were performed to identify the proteins in the selected size fraction.

RESULTS

The presence of cancer-specific anterior gradient 2 (AGR2) and absence of prostate-specific antigen (PSA)/KLK3 were confirmed by Western blotting. Proteomics also detected AGR2 among many other proteins, some outside the selected molecular weight range, as well.

CONCLUSIONS

Using this approach, the potentially harmful (to the mouse host) exogenously added collagenase was removed as well as other abundant prostatic proteins like ACPP/PAP and AZGP1 to preclude the generation of antibodies against these species. The paper presents an optimized scheme for convenient and rapid isolation of native proteins in any desired size range with minor modifications.

摘要

背景

前列腺癌细胞在基因表达上与其正常对应细胞不同。在前列腺癌中表达增加的编码分泌蛋白或细胞外蛋白的基因可能作为潜在的生物标志物。对于它们的检测和定量,基于单克隆抗体的检测方法最适合在临床环境中开发。获得抗体的一种方法是使用重组蛋白作为免疫原。然而,为每个已鉴定的候选物合成重组蛋白既耗时又昂贵。单独为所有已鉴定的候选物生成高质量抗体也不切实际。此外,蛋白质的非天然形式(例如重组形式)可能并不总是能产生有用的抗体。我们的方法是从前列腺癌组织标本中纯化一部分蛋白质用作免疫原。

方法

在本研究中,从 Gleason 评分 3+3、3+4 和 4+3 的病例中获取的 10 个癌组织标本在无血清组织培养基中用胶原酶消化成单细胞。胶原酶消化后细胞沉淀,将每个标本的无细胞上清液合并,通过超声处理、透析和 Amicon 超滤相结合的方法用于分离分子量在 10 - 30 kDa 范围内的蛋白质。进行蛋白质印迹和质谱(MS)蛋白质组学分析以鉴定所选大小级分中的蛋白质。

结果

通过蛋白质印迹证实了癌症特异性前梯度 2(AGR2)的存在以及前列腺特异性抗原(PSA)/激肽释放酶 3(KLK3)的缺失。蛋白质组学还在许多其他蛋白质中检测到了 AGR2,其中一些也不在所选分子量范围内。

结论

使用这种方法,去除了可能对小鼠宿主有害的外源性添加胶原酶以及其他丰富的前列腺蛋白,如酸性磷酸酶/前列腺酸性磷酸酶(ACPP/PAP)和锌α2糖蛋白 1(AZGP1),以防止产生针对这些物质的抗体。本文提出了一种经过优化的方案,只需进行少量修改即可方便快捷地分离任何所需大小范围内的天然蛋白质。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验